Galmed Pharmaceuticals
GLMD
$0.32
Share price
-6.66%
Change (1 day)
-91.09%
Change (1 year)
Categories
Galmed Pharmaceuticals (GLMD) - Net assets
Net assets on the balance sheet as of March 2024 : $12.75 M
According to Galmed Pharmaceuticals
's latest financial reports the company has $12.75 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Galmed Pharmaceuticals - Net assets on balance sheet (from 2013 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $13.42 M | -55.99% |
| 2021-12-31 | $30.49 M | -30.93% |
| 2020-12-31 | $44.15 M | -36.79% |
| 2019-12-31 | $69.85 M | -20.53% |
| 2018-12-31 | $87.89 M | 456.47% |
| 2017-12-31 | $15.79 M | 42.62% |
| 2016-12-31 | $11.07 M | -48.6% |
| 2015-12-31 | $21.54 M | -31.4% |
| 2014-12-31 | $31.4 M | -1709.79% |
| 2013-12-31 | $-1.96 M | -1.41% |
| 2012-12-31 | $-1.98 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Evoke Pharma
EVOK | $3.49 M | -72.58% | 🇺🇸 USA |
 Endo International
ENDPQ | -$6.6 B | -51,821.23% | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | -$0.17 B | -1,385.53% | 🇺🇸 USA |
 Catalent CTLT | $3.61 B | 28,208.25% | 🇺🇸 USA |